CN1622824A - 微生物表达的用于动物饲料的耐热植酸酶 - Google Patents
微生物表达的用于动物饲料的耐热植酸酶 Download PDFInfo
- Publication number
- CN1622824A CN1622824A CNA028284003A CN02828400A CN1622824A CN 1622824 A CN1622824 A CN 1622824A CN A028284003 A CNA028284003 A CN A028284003A CN 02828400 A CN02828400 A CN 02828400A CN 1622824 A CN1622824 A CN 1622824A
- Authority
- CN
- China
- Prior art keywords
- phytase
- heat
- animal
- stable phytase
- feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010011619 6-Phytase Proteins 0.000 title claims abstract description 303
- 229940085127 phytase Drugs 0.000 title claims abstract description 282
- 241001465754 Metazoa Species 0.000 title claims description 116
- 238000000034 method Methods 0.000 claims abstract description 156
- 235000013305 food Nutrition 0.000 claims abstract description 99
- 238000012545 processing Methods 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims description 124
- 210000004027 cell Anatomy 0.000 claims description 106
- 102000004190 Enzymes Human genes 0.000 claims description 101
- 108090000790 Enzymes Proteins 0.000 claims description 101
- 229940088598 enzyme Drugs 0.000 claims description 101
- 230000000694 effects Effects 0.000 claims description 93
- 230000014509 gene expression Effects 0.000 claims description 80
- 238000002360 preparation method Methods 0.000 claims description 52
- 238000006243 chemical reaction Methods 0.000 claims description 35
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 34
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 34
- 235000002949 phytic acid Nutrition 0.000 claims description 32
- 150000007523 nucleic acids Chemical class 0.000 claims description 31
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 30
- 229910019142 PO4 Inorganic materials 0.000 claims description 29
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 29
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 29
- 229920001184 polypeptide Polymers 0.000 claims description 29
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 29
- 239000000047 product Substances 0.000 claims description 29
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 28
- 239000010452 phosphate Substances 0.000 claims description 28
- 229910052698 phosphorus Inorganic materials 0.000 claims description 28
- 239000011574 phosphorus Substances 0.000 claims description 28
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 27
- 102000039446 nucleic acids Human genes 0.000 claims description 25
- 108020004707 nucleic acids Proteins 0.000 claims description 25
- 229940068041 phytic acid Drugs 0.000 claims description 23
- 239000000467 phytic acid Substances 0.000 claims description 23
- 238000005469 granulation Methods 0.000 claims description 21
- 230000003179 granulation Effects 0.000 claims description 21
- 229910052816 inorganic phosphate Inorganic materials 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 21
- 241000235058 Komagataella pastoris Species 0.000 claims description 20
- 239000004615 ingredient Substances 0.000 claims description 17
- 238000010438 heat treatment Methods 0.000 claims description 16
- 239000003674 animal food additive Substances 0.000 claims description 15
- 244000144977 poultry Species 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- 239000002778 food additive Substances 0.000 claims description 11
- 230000013595 glycosylation Effects 0.000 claims description 11
- 230000000813 microbial effect Effects 0.000 claims description 11
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 10
- 235000013373 food additive Nutrition 0.000 claims description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 10
- 239000011707 mineral Substances 0.000 claims description 10
- 240000008042 Zea mays Species 0.000 claims description 9
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 9
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 9
- 235000005822 corn Nutrition 0.000 claims description 9
- 238000006206 glycosylation reaction Methods 0.000 claims description 9
- 239000008187 granular material Substances 0.000 claims description 9
- 229940088594 vitamin Drugs 0.000 claims description 9
- 239000011782 vitamin Substances 0.000 claims description 9
- 235000013343 vitamin Nutrition 0.000 claims description 9
- 229930003231 vitamin Natural products 0.000 claims description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 9
- 241000235347 Schizosaccharomyces pombe Species 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 210000004051 gastric juice Anatomy 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 230000000050 nutritive effect Effects 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 241000235061 Pichia sp. Species 0.000 claims description 4
- 241000223259 Trichoderma Species 0.000 claims description 4
- 239000006227 byproduct Substances 0.000 claims description 4
- 239000006193 liquid solution Substances 0.000 claims description 4
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 4
- 201000002909 Aspergillosis Diseases 0.000 claims description 3
- 208000036641 Aspergillus infections Diseases 0.000 claims description 3
- 241000588722 Escherichia Species 0.000 claims description 3
- 241000235346 Schizosaccharomyces Species 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 230000008979 phosphorus utilization Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 210000005253 yeast cell Anatomy 0.000 claims description 3
- 241000228245 Aspergillus niger Species 0.000 claims description 2
- 241000235649 Kluyveromyces Species 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 241000221960 Neurospora Species 0.000 claims description 2
- 241000228143 Penicillium Species 0.000 claims description 2
- 241000589516 Pseudomonas Species 0.000 claims description 2
- 241000235527 Rhizopus Species 0.000 claims description 2
- 241000223230 Trichosporon Species 0.000 claims description 2
- 229940039696 lactobacillus Drugs 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000006053 animal diet Substances 0.000 claims 2
- 206010061418 Zygomycosis Diseases 0.000 claims 1
- 201000007524 mucormycosis Diseases 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 description 135
- 108020004414 DNA Proteins 0.000 description 86
- 102000053602 DNA Human genes 0.000 description 76
- 239000002773 nucleotide Substances 0.000 description 37
- 125000003729 nucleotide group Chemical group 0.000 description 37
- 102000040430 polynucleotide Human genes 0.000 description 36
- 108091033319 polynucleotide Proteins 0.000 description 36
- 239000002157 polynucleotide Substances 0.000 description 36
- 108091028043 Nucleic acid sequence Proteins 0.000 description 34
- 102000004169 proteins and genes Human genes 0.000 description 32
- 235000018102 proteins Nutrition 0.000 description 29
- 108020004999 messenger RNA Proteins 0.000 description 27
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 26
- 239000012634 fragment Substances 0.000 description 25
- 230000001105 regulatory effect Effects 0.000 description 25
- 230000001276 controlling effect Effects 0.000 description 24
- 235000021317 phosphate Nutrition 0.000 description 24
- 238000013519 translation Methods 0.000 description 23
- 150000001413 amino acids Chemical class 0.000 description 22
- 239000000243 solution Substances 0.000 description 20
- 235000001014 amino acid Nutrition 0.000 description 18
- 229920002477 rna polymer Polymers 0.000 description 18
- 230000008859 change Effects 0.000 description 17
- 239000013612 plasmid Substances 0.000 description 17
- 230000035897 transcription Effects 0.000 description 17
- 238000013518 transcription Methods 0.000 description 17
- 241000588724 Escherichia coli Species 0.000 description 16
- 241000287828 Gallus gallus Species 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 239000000758 substrate Substances 0.000 description 15
- 235000013330 chicken meat Nutrition 0.000 description 14
- 230000001939 inductive effect Effects 0.000 description 14
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 14
- 235000013594 poultry meat Nutrition 0.000 description 14
- 239000003623 enhancer Substances 0.000 description 13
- 239000001963 growth medium Substances 0.000 description 13
- 238000011144 upstream manufacturing Methods 0.000 description 13
- 230000000844 anti-bacterial effect Effects 0.000 description 12
- 230000012010 growth Effects 0.000 description 12
- 239000002609 medium Substances 0.000 description 12
- 238000003752 polymerase chain reaction Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000008685 targeting Effects 0.000 description 11
- 241000233866 Fungi Species 0.000 description 10
- 102000057297 Pepsin A Human genes 0.000 description 10
- 108090000284 Pepsin A Proteins 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 10
- 230000002255 enzymatic effect Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 239000003550 marker Substances 0.000 description 10
- 229940111202 pepsin Drugs 0.000 description 10
- 238000000746 purification Methods 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 230000005026 transcription initiation Effects 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 108091034057 RNA (poly(A)) Proteins 0.000 description 9
- 241000282898 Sus scrofa Species 0.000 description 9
- 239000000654 additive Substances 0.000 description 9
- 230000000996 additive effect Effects 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 239000013604 expression vector Substances 0.000 description 9
- 238000013467 fragmentation Methods 0.000 description 9
- 238000006062 fragmentation reaction Methods 0.000 description 9
- 235000010755 mineral Nutrition 0.000 description 9
- 238000012216 screening Methods 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 9
- 108091026890 Coding region Proteins 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 8
- 108091005804 Peptidases Proteins 0.000 description 8
- 230000008676 import Effects 0.000 description 8
- 230000008521 reorganization Effects 0.000 description 8
- 230000002103 transcriptional effect Effects 0.000 description 8
- 230000009261 transgenic effect Effects 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000002131 composite material Substances 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 238000005516 engineering process Methods 0.000 description 7
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 230000035772 mutation Effects 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 6
- 108700026244 Open Reading Frames Proteins 0.000 description 6
- 241000235648 Pichia Species 0.000 description 6
- 108091081024 Start codon Proteins 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 210000004913 chyme Anatomy 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 230000002068 genetic effect Effects 0.000 description 6
- 230000002779 inactivation Effects 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 230000000630 rising effect Effects 0.000 description 6
- 150000003839 salts Chemical group 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 108020004705 Codon Proteins 0.000 description 5
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 102220369447 c.1352G>A Human genes 0.000 description 5
- 238000004520 electroporation Methods 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 230000000977 initiatory effect Effects 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 102220023258 rs387907548 Human genes 0.000 description 5
- KQROHCSYOGBQGJ-UHFFFAOYSA-N 5-Hydroxytryptophol Chemical compound C1=C(O)C=C2C(CCO)=CNC2=C1 KQROHCSYOGBQGJ-UHFFFAOYSA-N 0.000 description 4
- 108010059892 Cellulase Proteins 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 101710150114 Protein rep Proteins 0.000 description 4
- 101710152114 Replication protein Proteins 0.000 description 4
- 108010034634 Repressor Proteins Proteins 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 108700026226 TATA Box Proteins 0.000 description 4
- 108020005038 Terminator Codon Proteins 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 230000002759 chromosomal effect Effects 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000002299 complementary DNA Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- -1 myo-inositol phosphates Chemical class 0.000 description 4
- 239000002777 nucleoside Substances 0.000 description 4
- 150000003833 nucleoside derivatives Chemical class 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 229960004249 sodium acetate Drugs 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 229940083982 sodium phytate Drugs 0.000 description 4
- 239000000600 sorbitol Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000009466 transformation Effects 0.000 description 4
- 230000014621 translational initiation Effects 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 108010013043 Acetylesterase Proteins 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 3
- 241000272525 Anas platyrhynchos Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 241000238424 Crustacea Species 0.000 description 3
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 3
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 3
- 108091029865 Exogenous DNA Proteins 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 102100036617 Monoacylglycerol lipase ABHD2 Human genes 0.000 description 3
- 108091092724 Noncoding DNA Proteins 0.000 description 3
- 241001645364 Phaffomyces Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 235000019764 Soybean Meal Nutrition 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 101710185494 Zinc finger protein Proteins 0.000 description 3
- 102100023597 Zinc finger protein 816 Human genes 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000005571 anion exchange chromatography Methods 0.000 description 3
- 230000000692 anti-sense effect Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008827 biological function Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000005277 cation exchange chromatography Methods 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 101150036876 cre gene Proteins 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 229960000367 inositol Drugs 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- YCIMNLLNPGFGHC-UHFFFAOYSA-N o-dihydroxy-benzene Natural products OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 3
- 238000012856 packing Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000010188 recombinant method Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 239000007974 sodium acetate buffer Substances 0.000 description 3
- 239000004455 soybean meal Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000272814 Anser sp. Species 0.000 description 2
- 102100032487 Beta-mannosidase Human genes 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 241001136487 Eurotium Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- 102000009661 Repressor Proteins Human genes 0.000 description 2
- 241001489223 Saccharomycodes Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000011609 ammonium molybdate Substances 0.000 description 2
- APUPEJJSWDHEBO-UHFFFAOYSA-P ammonium molybdate Chemical compound [NH4+].[NH4+].[O-][Mo]([O-])(=O)=O APUPEJJSWDHEBO-UHFFFAOYSA-P 0.000 description 2
- 235000018660 ammonium molybdate Nutrition 0.000 description 2
- 229940010552 ammonium molybdate Drugs 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 235000019730 animal feed additive Nutrition 0.000 description 2
- 235000019728 animal nutrition Nutrition 0.000 description 2
- 101150050411 appA gene Proteins 0.000 description 2
- 210000004436 artificial bacterial chromosome Anatomy 0.000 description 2
- 210000001106 artificial yeast chromosome Anatomy 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 108010055059 beta-Mannosidase Proteins 0.000 description 2
- 210000000013 bile duct Anatomy 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000003593 chromogenic compound Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000004567 concrete Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 230000007515 enzymatic degradation Effects 0.000 description 2
- YQDHCCVUYCIGSW-LBPRGKRZSA-N ethyl (2s)-2-benzamido-5-(diaminomethylideneamino)pentanoate Chemical group NC(=N)NCCC[C@@H](C(=O)OCC)NC(=O)C1=CC=CC=C1 YQDHCCVUYCIGSW-LBPRGKRZSA-N 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 102000035122 glycosylated proteins Human genes 0.000 description 2
- 108091005608 glycosylated proteins Proteins 0.000 description 2
- 238000004191 hydrophobic interaction chromatography Methods 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 210000001630 jejunum Anatomy 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 229960004502 levodopa Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000015927 pasta Nutrition 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 230000035479 physiological effects, processes and functions Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960002203 tilactase Drugs 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- FCHBECOAGZMTFE-ZEQKJWHPSA-N (6r,7r)-3-[[2-[[4-(dimethylamino)phenyl]diazenyl]pyridin-1-ium-1-yl]methyl]-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=CC=[N+]1CC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CC=3SC=CC=3)[C@H]2SC1 FCHBECOAGZMTFE-ZEQKJWHPSA-N 0.000 description 1
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
- VGONTNSXDCQUGY-RRKCRQDMSA-N 2'-deoxyinosine Chemical group C1[C@H](O)[C@@H](CO)O[C@H]1N1C(N=CNC2=O)=C2N=C1 VGONTNSXDCQUGY-RRKCRQDMSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 108010080981 3-phytase Proteins 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- 108010051457 Acid Phosphatase Proteins 0.000 description 1
- 102000013563 Acid Phosphatase Human genes 0.000 description 1
- 101100148259 Actinobacillus pleuropneumoniae apxIIA gene Proteins 0.000 description 1
- 108010000239 Aequorin Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101710186708 Agglutinin Proteins 0.000 description 1
- 101710194180 Alcohol oxidase 1 Proteins 0.000 description 1
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 description 1
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 108020004491 Antisense DNA Proteins 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 101100238293 Arabidopsis thaliana MOR1 gene Proteins 0.000 description 1
- 241001225321 Aspergillus fumigatus Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 101710130006 Beta-glucanase Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 239000012617 Butyl Sepharose™ 4 Fast Flow Substances 0.000 description 1
- 101100327917 Caenorhabditis elegans chup-1 gene Proteins 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 101001096557 Dickeya dadantii (strain 3937) Rhamnogalacturonate lyase Proteins 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 206010013183 Dislocation of vertebra Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 101000688187 Escherichia coli (strain K12) Phytase AppA Proteins 0.000 description 1
- 241000700662 Fowlpox virus Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 101150094690 GAL1 gene Proteins 0.000 description 1
- 102100021736 Galectin-1 Human genes 0.000 description 1
- 102100024637 Galectin-10 Human genes 0.000 description 1
- 101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
- 101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108010070675 Glutathione transferase Proteins 0.000 description 1
- 102000005720 Glutathione transferase Human genes 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 101710146024 Horcolin Proteins 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- MXSMLDVUIRKKID-UHFFFAOYSA-N Ingol Natural products C1=C(C)C(O)C(O)C2C(C)(C)C2C(O)C(C)C(=O)C23CC(C)C(O)C21O3 MXSMLDVUIRKKID-UHFFFAOYSA-N 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- 108010054278 Lac Repressors Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 101710189395 Lectin Proteins 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 101710179758 Mannose-specific lectin Proteins 0.000 description 1
- 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
- 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101150012394 PHO5 gene Proteins 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010059820 Polygalacturonase Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 101710193739 Protein RecA Proteins 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 235000019779 Rapeseed Meal Nutrition 0.000 description 1
- 241000190932 Rhodopseudomonas Species 0.000 description 1
- 108010086876 S1-RNase Proteins 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241001655322 Streptomycetales Species 0.000 description 1
- 241000271567 Struthioniformes Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 108020005202 Viral DNA Proteins 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 235000019752 Wheat Middilings Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QGKAVFXNTADNHB-UHFFFAOYSA-N [Mg].[K].[Ca] Chemical compound [Mg].[K].[Ca] QGKAVFXNTADNHB-UHFFFAOYSA-N 0.000 description 1
- HJCUCLCJVVFBTD-UHFFFAOYSA-N [Na].[Na].S(O)(O)(=O)=O Chemical compound [Na].[Na].S(O)(O)(=O)=O HJCUCLCJVVFBTD-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000910 agglutinin Substances 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- 230000000735 allogeneic effect Effects 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- UPEZCKBFRMILAV-UHFFFAOYSA-N alpha-Ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C(O)CCC(C)(C)O)C)CCC33O)C)C3=CC(=O)C21 UPEZCKBFRMILAV-UHFFFAOYSA-N 0.000 description 1
- 102000005840 alpha-Galactosidase Human genes 0.000 description 1
- 108010030291 alpha-Galactosidase Proteins 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 239000010828 animal waste Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000003816 antisense DNA Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 108010052439 arabinoxylanase Proteins 0.000 description 1
- UNTBPXHCXVWYOI-UHFFFAOYSA-O azanium;oxido(dioxo)vanadium Chemical compound [NH4+].[O-][V](=O)=O UNTBPXHCXVWYOI-UHFFFAOYSA-O 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- QTPILKSJIOLICA-UHFFFAOYSA-N bis[hydroxy(phosphonooxy)phosphoryl] hydrogen phosphate Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(O)=O QTPILKSJIOLICA-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 102220369446 c.1274G>A Human genes 0.000 description 1
- 102220369445 c.668T>C Human genes 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- ZYWFEOZQIUMEGL-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol;phenol Chemical compound ClC(Cl)Cl.CC(C)CCO.OC1=CC=CC=C1 ZYWFEOZQIUMEGL-UHFFFAOYSA-N 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000002742 combinatorial mutagenesis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 201000003740 cowpox Diseases 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 101150056310 gem1 gene Proteins 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 238000012226 gene silencing method Methods 0.000 description 1
- 102000054767 gene variant Human genes 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- TVZISJTYELEYPI-UHFFFAOYSA-N hypodiphosphoric acid Chemical compound OP(O)(=O)P(O)(O)=O TVZISJTYELEYPI-UHFFFAOYSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- MXSMLDVUIRKKID-IWHJHRENSA-N ingol Chemical compound C/1=C(C)/[C@H](O)[C@H](O)[C@@H]2C(C)(C)[C@@H]2[C@H](O)[C@H](C)C(=O)[C@@]23C[C@H](C)[C@H](O)[C@]2\1O3 MXSMLDVUIRKKID-IWHJHRENSA-N 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 101150109249 lacI gene Proteins 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 230000002366 lipolytic effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000010327 methods by industry Methods 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- VLAPMBHFAWRUQP-UHFFFAOYSA-L molybdic acid Chemical compound O[Mo](O)(=O)=O VLAPMBHFAWRUQP-UHFFFAOYSA-L 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000021232 nutrient availability Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 150000003906 phosphoinositides Chemical class 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 229940116540 protein supplement Drugs 0.000 description 1
- 235000005974 protein supplement Nutrition 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 208000009305 pseudorabies Diseases 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 210000001187 pylorus Anatomy 0.000 description 1
- 239000004456 rapeseed meal Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 102220023257 rs387907546 Human genes 0.000 description 1
- 102220023256 rs387907547 Human genes 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 238000002133 sample digestion Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000005245 sintering Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 101150101900 uidA gene Proteins 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- WQEVDHBJGNOKKO-UHFFFAOYSA-K vanadic acid Chemical compound O[V](O)(O)=O WQEVDHBJGNOKKO-UHFFFAOYSA-K 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03008—3-Phytase (3.1.3.8)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/25—Shaping or working-up of animal feeding-stuffs by extrusion
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/30—Removing undesirable substances, e.g. bitter substances
- A23L11/33—Removing undesirable substances, e.g. bitter substances using enzymes; Enzymatic transformation of pulses or legumes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
Abstract
Description
性质 | AppA | NatuPhos | Nov9x | appA-2* |
SA# | 10 | 1 | 10 | 10 |
热稳定性 | 在100℃是3% | ND | 在100℃是40% | ND |
Claims (72)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34452301P | 2001-12-28 | 2001-12-28 | |
US60/344,523 | 2001-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1622824A true CN1622824A (zh) | 2005-06-01 |
CN100406561C CN100406561C (zh) | 2008-07-30 |
Family
ID=23350879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB028284003A Expired - Lifetime CN100406561C (zh) | 2001-12-28 | 2002-12-30 | 微生物表达的用于动物饲料的耐热植酸酶 |
Country Status (14)
Country | Link |
---|---|
US (4) | US7135323B2 (zh) |
EP (1) | EP1465655A4 (zh) |
CN (1) | CN100406561C (zh) |
AR (1) | AR037987A1 (zh) |
AU (1) | AU2002364266B2 (zh) |
BR (1) | BR0215400A (zh) |
CA (1) | CA2471857C (zh) |
EG (1) | EG24067A (zh) |
MX (1) | MX249283B (zh) |
MY (1) | MY139056A (zh) |
NZ (1) | NZ533882A (zh) |
TW (1) | TWI262083B (zh) |
WO (1) | WO2003057247A1 (zh) |
ZA (1) | ZA200405092B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010054513A1 (en) * | 2008-11-14 | 2010-05-20 | Fujian Fuda Biotech Co. Ltd. | A thermotolerant non-k12 escherichia coli phytase and its production |
CN103820345A (zh) * | 2014-01-17 | 2014-05-28 | 北京理工大学 | 一种提高酿酒酵母耐热性的分子调控方法 |
CN108460235A (zh) * | 2018-04-04 | 2018-08-28 | 西南科技大学 | 一种通过数学模型预测猪饲料磷表观全肠道消化率的方法 |
CN108753754A (zh) * | 2012-02-07 | 2018-11-06 | 丹尼斯科美国公司 | 糖基化作为植酸酶的稳定剂 |
CN114085825A (zh) * | 2013-03-14 | 2022-02-25 | 巴斯夫酶有限责任公司 | 肌醇六磷酸酶制剂 |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451572B1 (en) | 1998-06-25 | 2002-09-17 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
PT2335501T (pt) | 2001-10-31 | 2016-10-28 | Huvepharma Ad | Alimento animal contendo fitase e método |
MY139056A (en) * | 2001-12-28 | 2009-08-28 | Ab Enzymes Gmbh | Microbially-expressed thermotolerant phytase for animal feed |
CN1833168A (zh) * | 2003-07-07 | 2006-09-13 | 辛根塔参与股份公司 | 用于检测饲料酶的试剂、方法和试剂盒 |
CN101056540A (zh) * | 2004-09-27 | 2007-10-17 | 诺维信公司 | 酶颗粒 |
GB0422052D0 (en) | 2004-10-04 | 2004-11-03 | Dansico As | Enzymes |
DE102004050410A1 (de) * | 2004-10-15 | 2006-06-08 | Ab Enzymes Gmbh | Polypeptid mit Phytaseaktivität und dieses codierende Nucleotidsequenz |
GB0423139D0 (en) | 2004-10-18 | 2004-11-17 | Danisco | Enzymes |
US7658922B2 (en) | 2005-06-24 | 2010-02-09 | Ab Enzymes Gmbh | Monoclonal antibodies, hybridoma cell lines, methods and kits for detecting phytase |
GB0600913D0 (en) | 2006-01-17 | 2006-02-22 | Syngenta Ltd | Improvements in or relating to organic compounds |
US8518926B2 (en) * | 2006-04-10 | 2013-08-27 | Knopp Neurosciences, Inc. | Compositions and methods of using (R)-pramipexole |
JP2009537565A (ja) | 2006-05-16 | 2009-10-29 | ノップ ニューロサイエンシーズ、インク. | R(+)およびs(−)プラミペキソール組成とそれを利用する方法 |
EP2069486A2 (en) | 2006-08-03 | 2009-06-17 | Cornell Research Foundation, Inc. | Phytases with improved thermal stability |
ES2531135T3 (es) | 2006-09-21 | 2015-03-11 | Basf Enzymes Llc | Fitasas, ácidos nucleicos que las codifican y métodos para su producción y uso |
DE102006053059A1 (de) | 2006-11-10 | 2008-05-15 | Ab Enzymes Gmbh | Polypeptid mit Phytaseaktivität und erhöhter Temperaturstabilität der Enzymaktivität sowie dieses codierende Nukleotidsequenz |
US8524695B2 (en) * | 2006-12-14 | 2013-09-03 | Knopp Neurosciences, Inc. | Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same |
US8143046B2 (en) | 2007-02-07 | 2012-03-27 | Danisco Us Inc., Genencor Division | Variant Buttiauxella sp. phytases having altered properties |
AU2008224844B2 (en) | 2007-03-14 | 2012-08-09 | Knopp Neurosciences, Inc. | Synthesis of chirally purified substituted benzothiazole diamines |
CA2704271C (en) * | 2007-12-03 | 2016-07-19 | Syngenta Participations Ag | Engineering enzymatically susceptible phytases |
WO2009100231A2 (en) * | 2008-02-06 | 2009-08-13 | The Regents Of The University Of California | Short chain volatile isoprene hydrocarbon production using the mevalonic acid pathway in genetically engineered yeast and fungi |
DK3118309T3 (da) * | 2008-04-18 | 2020-12-14 | Danisco Us Inc | Buttiauxella sp. phytasevarianter |
EP2140772A1 (en) * | 2008-07-03 | 2010-01-06 | Nestec S.A. | Temperature-induced delivery of nutrients by micro-organisms in the gastrointestinal tract |
EP2334185A4 (en) * | 2008-08-19 | 2011-09-21 | Knopp Neurosciences Inc | COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL |
WO2010051489A1 (en) * | 2008-10-31 | 2010-05-06 | Sapphire Energy, Inc. | Animal feedstock comprising genetically modified algae |
US9695403B2 (en) | 2009-05-21 | 2017-07-04 | Syngenta Participations Ag | Phytases, nucleic acids encoding them and methods for making and using them |
WO2011150221A2 (en) * | 2010-05-26 | 2011-12-01 | Knopp Neurosciences, Inc. | Compounds and methods of modulating mitochondrial bioenergetic efficiency through an interaction with atp synthase (complex v) and its subunits |
ES2758563T3 (es) * | 2011-06-09 | 2020-05-05 | Novozymes As | Fusión de moléculas bioactivas |
WO2013096816A1 (en) | 2011-12-22 | 2013-06-27 | Biogen Idec Ma Inc. | Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds |
GB201213801D0 (en) | 2012-08-03 | 2012-09-12 | Dupont Nutrition Biosci Aps | Feed additive composition |
US9662313B2 (en) | 2013-02-28 | 2017-05-30 | Knopp Biosciences Llc | Compositions and methods for treating amyotrophic lateral sclerosis in responders |
ES2961268T3 (es) | 2013-03-08 | 2024-03-11 | Biogrammatics Inc | Promotores de levadura para la expresión de proteínas |
BR112015021753B1 (pt) | 2013-03-08 | 2023-02-23 | Keck Graduate Institute Of Applied Life Sciences | Ácidos nucleicos isolados de pichia pastoris, vetor de expressão, células hospedeiras de levedura e construto de dna, bem como método para produzir uma proteína |
GB201308828D0 (en) | 2013-03-12 | 2013-07-03 | Verenium Corp | Phytase |
PL3019167T3 (pl) | 2013-07-12 | 2021-06-14 | Knopp Biosciences Llc | Leczenie podwyższonych poziomów eozynofili i/lub bazofili |
US9468630B2 (en) | 2013-07-12 | 2016-10-18 | Knopp Biosciences Llc | Compositions and methods for treating conditions related to increased eosinophils |
CN105408492A (zh) | 2013-07-25 | 2016-03-16 | 巴斯夫酶有限责任公司 | 肌醇六磷酸酶 |
ES2871556T3 (es) | 2013-08-13 | 2021-10-29 | Knopp Biosciences Llc | Composiciones y métodos para el tratamiento de la urticaria crónica |
US9642840B2 (en) | 2013-08-13 | 2017-05-09 | Knopp Biosciences, Llc | Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders |
WO2015119681A1 (en) * | 2014-02-04 | 2015-08-13 | University Of Florida Research Foundation, Inc. | Pteris vittata phytase nucleotide and amino acid sequences and methods of use |
CN104928315A (zh) * | 2015-07-02 | 2015-09-23 | 江南大学 | 一株表达赖氨酸氨肽酶的重组毕赤酵母的构建及表达方法 |
CN107353327A (zh) | 2017-03-30 | 2017-11-17 | 南京百斯杰生物工程有限公司 | 植酸酶在黑曲霉中表达 |
EP3453719A1 (en) | 2017-09-07 | 2019-03-13 | Huvepharma Eood | New thermostable phytases with high catalytic efficacy |
CN107488642B (zh) * | 2017-09-30 | 2020-08-18 | 山东隆科特酶制剂有限公司 | 一种植酸酶突变体及其应用 |
CN107586765A (zh) * | 2017-10-20 | 2018-01-16 | 山东奥博生物科技有限公司 | 一种植酸酶的工业发酵方法 |
WO2020008081A1 (es) | 2018-07-03 | 2020-01-09 | Fertinagro Biotech, S.L. | Aditivo alimentario para piensos y utilización del mismo |
CN110042065B (zh) * | 2018-11-15 | 2020-10-02 | 天津挑战博德生物技术有限公司 | 甲醇利用慢型毕赤酵母菌株及其制备方法和应用 |
CN111349576B (zh) * | 2018-12-20 | 2022-05-20 | 中粮生物科技(北京)有限公司 | 组成型表达猪胃蛋白酶原a的毕赤酵母工程菌及其应用 |
EP4076002A1 (en) * | 2019-12-19 | 2022-10-26 | DuPont Nutrition Biosciences ApS | Diet formulations |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873192A (en) | 1987-02-17 | 1989-10-10 | The United States Of America As Represented By The Department Of Health And Human Services | Process for site specific mutagenesis without phenotypic selection |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6358722B1 (en) * | 1994-04-25 | 2002-03-19 | Roche Vitamins, Inc. | Heat tolerant phytases |
DE69535097T2 (de) * | 1994-04-25 | 2006-12-28 | Dsm Ip Assets B.V. | Polypeptide mit phytase Wirkung |
US6291221B1 (en) | 1994-04-25 | 2001-09-18 | Roche Vitamins Inc. | Heat tolerant phytases |
US6699704B1 (en) | 1994-04-25 | 2004-03-02 | Roche Vitamins Inc. | Heat tolerant phytases |
US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
US6358709B1 (en) | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
CN1222195A (zh) * | 1996-06-14 | 1999-07-07 | 加拿大农业及农业食品部 | 编码反刍微生物肌醇六磷酸酶的dna序列 |
NZ330940A (en) | 1997-07-24 | 2000-02-28 | F | Production of consensus phytases from fungal origin using computer programmes |
US6720014B1 (en) * | 1997-08-13 | 2004-04-13 | Diversa Corporation | Phytase-containing foodstuffs and methods of making and using them |
US6855365B2 (en) | 1997-08-13 | 2005-02-15 | Diversa Corporation | Recombinant bacterial phytases and uses thereof |
US6183740B1 (en) | 1997-08-13 | 2001-02-06 | Diversa Corporation | Recombinant bacterial phytases and uses thereof |
US5876997A (en) * | 1997-08-13 | 1999-03-02 | Diversa Corporation | Phytase |
US6451572B1 (en) * | 1998-06-25 | 2002-09-17 | Cornell Research Foundation, Inc. | Overexpression of phytase genes in yeast systems |
BR0009516B1 (pt) | 1999-03-31 | 2013-09-10 | vetor recombinante e célula hospedeira microbiana. | |
US20030101476A1 (en) * | 2000-12-12 | 2003-05-29 | Short Jay M. | Recombinant phytases and uses thereof |
MY139056A (en) * | 2001-12-28 | 2009-08-28 | Ab Enzymes Gmbh | Microbially-expressed thermotolerant phytase for animal feed |
TW200305430A (en) * | 2001-12-28 | 2003-11-01 | Syngenta Participations Ag | Thermotolerant phytase for animal feed |
-
2002
- 2002-12-27 MY MYPI20024913A patent/MY139056A/en unknown
- 2002-12-27 TW TW091137674A patent/TWI262083B/zh not_active IP Right Cessation
- 2002-12-28 EG EG2002121400A patent/EG24067A/xx active
- 2002-12-30 AR ARP020105149A patent/AR037987A1/es active IP Right Grant
- 2002-12-30 WO PCT/US2002/041785 patent/WO2003057247A1/en not_active Application Discontinuation
- 2002-12-30 AU AU2002364266A patent/AU2002364266B2/en not_active Expired
- 2002-12-30 CN CNB028284003A patent/CN100406561C/zh not_active Expired - Lifetime
- 2002-12-30 MX MXPA04006388 patent/MX249283B/es active IP Right Grant
- 2002-12-30 BR BR0215400-5A patent/BR0215400A/pt not_active Application Discontinuation
- 2002-12-30 EP EP02799344A patent/EP1465655A4/en not_active Ceased
- 2002-12-30 CA CA2471857A patent/CA2471857C/en not_active Expired - Lifetime
- 2002-12-30 NZ NZ533882A patent/NZ533882A/en not_active IP Right Cessation
- 2002-12-30 US US10/334,672 patent/US7135323B2/en not_active Expired - Lifetime
-
2004
- 2004-06-25 ZA ZA2004/05092A patent/ZA200405092B/en unknown
-
2006
- 2006-03-20 US US11/384,670 patent/US7138260B2/en not_active Expired - Lifetime
- 2006-10-17 US US11/582,180 patent/US7252983B2/en not_active Expired - Lifetime
-
2007
- 2007-06-15 US US11/818,681 patent/US7632668B2/en not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010054513A1 (en) * | 2008-11-14 | 2010-05-20 | Fujian Fuda Biotech Co. Ltd. | A thermotolerant non-k12 escherichia coli phytase and its production |
CN102209785B (zh) * | 2008-11-14 | 2013-04-03 | 福建福大百特科技发展有限公司 | 一种耐热非-k12大肠杆菌植酸酶及其生产 |
US8652820B2 (en) | 2008-11-14 | 2014-02-18 | Fujian Fuda Biotech Co. Ltd. | Thermotolerant Non-K12 Escherichia coli phytase and its production |
CN108753754A (zh) * | 2012-02-07 | 2018-11-06 | 丹尼斯科美国公司 | 糖基化作为植酸酶的稳定剂 |
CN114085825A (zh) * | 2013-03-14 | 2022-02-25 | 巴斯夫酶有限责任公司 | 肌醇六磷酸酶制剂 |
CN103820345A (zh) * | 2014-01-17 | 2014-05-28 | 北京理工大学 | 一种提高酿酒酵母耐热性的分子调控方法 |
CN103820345B (zh) * | 2014-01-17 | 2016-07-13 | 北京理工大学 | 一种提高酿酒酵母耐热性的分子调控方法 |
CN108460235A (zh) * | 2018-04-04 | 2018-08-28 | 西南科技大学 | 一种通过数学模型预测猪饲料磷表观全肠道消化率的方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2471857A1 (en) | 2003-07-17 |
MX249283B (es) | 2007-09-21 |
WO2003057247A1 (en) | 2003-07-17 |
US20070087410A1 (en) | 2007-04-19 |
US7135323B2 (en) | 2006-11-14 |
NZ533882A (en) | 2006-04-28 |
CA2471857C (en) | 2014-02-18 |
TWI262083B (en) | 2006-09-21 |
MXPA04006388A (es) | 2005-07-13 |
BR0215400A (pt) | 2005-03-29 |
CN100406561C (zh) | 2008-07-30 |
AU2002364266A1 (en) | 2003-07-24 |
AU2002364266B2 (en) | 2008-04-24 |
AR037987A1 (es) | 2004-12-22 |
US7252983B2 (en) | 2007-08-07 |
EP1465655A4 (en) | 2005-06-08 |
US7138260B2 (en) | 2006-11-21 |
EP1465655A1 (en) | 2004-10-13 |
MY139056A (en) | 2009-08-28 |
TW200306203A (en) | 2003-11-16 |
US20030157646A1 (en) | 2003-08-21 |
EG24067A (en) | 2008-05-08 |
US7632668B2 (en) | 2009-12-15 |
US20060183213A1 (en) | 2006-08-17 |
US20080131560A1 (en) | 2008-06-05 |
ZA200405092B (en) | 2005-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1622824A (zh) | 微生物表达的用于动物饲料的耐热植酸酶 | |
CN1093379C (zh) | 一种酶饲料添加剂和包含它的动物饲料 | |
CN1195846C (zh) | 隔孢伏革菌植酸酶 | |
CN1053013C (zh) | 微生物植酸酶的克隆及表达 | |
CN101389645B (zh) | 具有木聚糖酶活性的多肽和编码它的多核苷酸 | |
CN100347303C (zh) | 具有改良的肌醇六磷酸酶活性的磷酸酶 | |
CN101679986B (zh) | 哈夫尼菌属肌醇六磷酸酶 | |
CN1165614C (zh) | 含有木聚糖酶的动物饲料添加剂 | |
CN1309699A (zh) | 植酸酶变体 | |
CN103224918B (zh) | 具有肌醇六磷酸酶活性的多肽和编码它的多核苷酸 | |
CN101035893A (zh) | 弗氏柠檬酸杆菌肌醇六磷酸酶及同源物 | |
CN1610510A (zh) | 含有肌醇六磷酸酶的动物食物和方法 | |
CN101035892A (zh) | 具有肌醇六磷酸酶活性的多肽及编码其的多核苷酸 | |
CN1630719A (zh) | 肌醇六磷酸酶变体 | |
CN1622825A (zh) | 用于动物饲料的耐热植酸酶 | |
CN1454259A (zh) | 篮霉菌木聚糖酶 | |
KR100790918B1 (ko) | 에스케리챠 콜리 피타아제의 부위-지향성 돌연변이유발 | |
CN1622761A (zh) | 热稳定酶组合物 | |
CN1451039A (zh) | 肌醇六磷酸酶、编码肌醇六磷酸酶的核酸及包含有此核酸的载体和宿主细胞 | |
CN1214081A (zh) | 具有肌醇六磷酸酶活性的多肽和编码此肽的核酸 | |
CN107072251A (zh) | 具有丝氨酸蛋白酶活性的多肽和编码它们的多核苷酸以及它们在动物饲料方面的应用 | |
CN101052715A (zh) | 酶 | |
CN101080491A (zh) | 具有植酸酶活性的多肽和编码多肽的核苷酸序列 | |
CN1845989A (zh) | 抗微生物剂的重组产生 | |
CN101631855B (zh) | 具有肌醇六磷酸酶活性且该酶活性的温度稳定性增强的多肽及编码所述多肽的核苷酸序列 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SYNGENTA CO.,LTD. Free format text: FORMER OWNER: SYNGENTA CO.,LTD.; DIVERSA CORP. Effective date: 20080627 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20080627 Address after: Basel, Switzerland Patentee after: SYNGENTA PARTICIPATIONS AG Address before: Basel, Switzerland Co-patentee before: Diversa Corp. Patentee before: SYNGENTA PARTICIPATIONS AG |
|
ASS | Succession or assignment of patent right |
Owner name: AB ENZYME CO., LTD. Free format text: FORMER OWNER: SYNGENTA CO.,LTD. Effective date: 20090821 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090821 Address after: German Damm schardt Patentee after: AB Enzyme Co.,Ltd. Address before: Basel, Switzerland Patentee before: Syngenta Participations AG |
|
CX01 | Expiry of patent term |
Granted publication date: 20080730 |
|
CX01 | Expiry of patent term |